The two organizations will advance collaborative research on emerging and infectious diseases and fast spreading viral infections by identifying promising diagnostic tools, neutralizing antibodies, vaccines, and drugs, according to a company release.

Celdara said that initially the partnership will focus on SARS-CoV-2 and future pandemic threats.

Moderna inks South Korean mRNA vaccine collaborations
Moderna has inked two memoranda of understanding agreements with South Korea for messenger RNA (mRNA) vaccine research and manufacturing in that country.

Biogen, Ginkgo partner on enhanced AAV manufacturing for gene therapies
Biogen and Ginkgo Bioworks will collaborate to develop improved methods for manufacturing recombinant adeno-associated virus (AAV)-based vectors.

Biogen, Envisagenics collaborate on RNA splicing
Biogen and Envisagenics have announced a new collaboration to advance RNA splicing research within central nervous system diseases.

Sciex, Waters collaborate to offer fully integrated LC-MS systems
Sciex and Waters have inked a deal to provide integrated liquid chromatography and mass spectrometry (LC-MC) systems.

NIH funds Celdara for pandemic influenza antiviral development
The U.S. National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases has awarded Celdara Medical a Small Business Innovation...